Posts

Showing posts with the label anti-parasitic

Ivermectin Dosage Guide for Humans (2026)

Image
In this Article : Overview of Ivermectin Dosage | Ivermectin Dosage for Adults | Ivermectin Dosage for Children | Ivermectin dosage restrictions | How to take ivermectin | Ivermectin dosage FAQs The prescribed dosage for ivermectin oral tablets depends on the type of parasitic infection you have and your body weight. Ivermectin is typically taken as a single dose. Repeat doses may be needed in some cases. Specifically, ivermectin oral tablet is approved by the Food and Drug Administration (FDA) to treat the following conditions in adults and certain children: a parasitic infection in the intestinal tract called strongyloidiasis a parasitic infection of the eyes and skin called onchocerciasis  (River Blindness) Ivermectin oral tablet is a generic medication and belongs to a drug class called antiparasitic medications. It is also available in a brand-name version called Stromectol. This article describes the dosages of ivermectin oral tablets, as well as the medication’s stren...

Parasite Killers for Cancer Treatment: An Updated Review (2026)

Image
Introduction There is increasing interest in the potential use of Ivermectin and Fenbendazole as cancer treatments. This guide compiles key resources—including research articles, protocols, and expert insights—exploring their possible roles in cancer therapy. Several case reports for fenbendazole, ivermectin and mebendazole have revealed promising effects of these drugs in human patients having variable types of cancers.  The present paper aimed to review recent trends in use of ivermectin, fenbendazole and mebendazole as new promising anti-cancer agents.   Ivermectin: Key Resources Ivermectin is one of the top non-standard or non-conventional drug for cancer. Informative Article and Videos June 10, 2024  - "15 minutes with Dr.Makis" - Episode 018: High Dose IVERMECTIN and CANCER 2024 Studies Baghli et al 2024 -  Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: ...

Niclosamide for Cancer and other Diseases - 2025 Review Paper from China

Image
Niclosamide was approved by FDA in 1982 for treating tapeworm infections, and was designated an essential drug by WHO. Niclosamide for Cancer Mechanisms: 1. Mitochondrial uncoupling - this is its major anti-cancer mechanism Niclosamide acts like a mild “leak” in the mitochondrial membrane, letting protons slip across without making ATP. This increases oxygen use, lowers ATP levels, raises AMP/ATP ratio & activates AMPK (energy sensor) to inhibit mTOR (slows down cancer cell growth). Cancer cells, which often rely on inefficient energy pathways (Warburg effect), are especially vulnerable. This can lead to inhibition of ATP synthesis, exhausting cellular energy reserves, metabolic stress, and cell death. 2. Signal pathway modulation - It inhibits several “pro-cancer” pathways, including: - Wnt/β-catenin (important in cancer proliferation, especially colorectal). - mTOR (controls cell proliferation, growth and metabolism). - Notch pathway (controls proliferation, growth, ...

Labels

Show more

Archive

Show more